Метаболічні порушення у хворих на гіпертонічну хворобу як науковий напрямок кафедри сімейної медицини

Автор(и)

  • S. V. Biletskyi
  • O. A. Petrynych
  • T. V. Kazantseva

DOI:

https://doi.org/10.24061/2413-0737.XVIII.2.70.2014.96

Ключові слова:

кафедра, науковий напрямок, гіпертонічна хвороба, метаболічні порушення

Анотація

У роботі узагальнюються результати наукових досліджень кафедри сімейної медицини щодо вивчення метаболічних порушень у хворих на гіпертонічну хворобу та їх зміни під впливом патогенетично обґрунтованого лікування.

Посилання

Amosova KM, Yaremenko OB, Kovhanich TO. Efficacy and tolerability of the drug lercanidipine in patients with mild to moderate hypertension. Ukrains'kyi kardiolohichnyi zhurnal. 2004;3:42-7. (in Ukrainian).

Bilets'kyi SV, Petrynych OA, Kazantseva TV. Effect of pioglitazone on proteolysis and hemostasis in patients with hypertension combined with diabetes of the second type. Bukovyns'kyi medychnyi visnyk. 2013;17(1):19-2. (in Ukrainian).

Bilets'kyi SV, Kazantseva TV, Zorii IA. Clinical and biochemical markers of metabolic syndrome, hypertension in adults and children. Bukovyns'kyi medychnyi visnyk. 2008;12(1):75-1. (in Ukrainian).

Bilets'kyi SV, Petrynych OA, Kazantseva TV, Pavlovych LB. Hemodynamic and metabolic disorders in patients with hypertension combined with diabetes mellitus type 2, correction possibilities. Chernivtsi: Bukovyns'kyi derzhavnyi medychnyi universytet; 2012. 294 p. (in Ukrainian).

Biletskiy SV, Gozhenko AI, Bobylev AV. Hypoxic-hypercapnic training in cardiology. Chernivtsi: BDMU; 2007. 148 p. (in Russian).

Efimov AS, Sokolova LK, Rybchenko YuB. Diabetes and heart. Available at: http://www.m-l.com.ua/?aid=495 (30.07.2009).

Health care morbidity and Ukraine in 2006. Statistical Bulletin. State Statistics Committee of Ukraine. Kyiv; 2007. 45 p. (in Ukrainian).

Zorii IA, Biletskiy SV. Differential diagnosis of hypothalamic and metabolic syndrome in children and adolescents. Klinichna ta eksperymental'na patolohiia. 2008;7(1):46-0. (in Ukrainian).

Zorii IA, Biletskiy SV, Shevchuk NM. Clinical and biochemical markers of metabolic syndrome in children and adolescents. Bukovyns'kyi medychnyi visnyk. 2007;11(2):40-4. (in Ukrainian).

Kazantseva TV, Biletskiy SV. Imidazoline receptor agonist - fiziotenz therapy in patients with hypertension and type 2 diabetes. Bukovyns'kyi medychnyi visnyk. 2006;10(2):26-9. (in Ukrainian).

Kazantseva TV, Biletskiy SV. The use of hypoxic-hiperkapnichnyh exercise by breathing through an additional "dead" space in the treatment of hypertensive patients with concomitant diabetes mellitus type 2. Bukovyns'kyi medychnyi visnyk. 2007;11(1):26-9. (in Ukrainian).

Kolomoiets' MIu, Taschuk VK. Chernivtsi school therapists. Internal Medicine. 2007. Available at: http:// www.mif-ua.com/archive/article/2859 (in Ukrainian)

Kosygina AV, Vasyukova OV. New in the pathogenesis of obesity: adipokines - hormones adipose tissue. Problemy endokrinologii. 2009;55(1):44-9. (in Russian).

Petrynych OA, Bilets'kyi SV, Mel'nychuk LV. Features of metabolic disorders in hypertensive patients and in combination with diabetes type 2: the relationship with insulin resistance. Bukovyns'kyi medychnyi visnyk. 2009;13(3):61-5. (in Ukrainian).

Pan'kiv VI. Insulin resistance as a key pathophysiologic mechanism of the metabolic syndrome. Praktychna anhiolohiia. 2012;5-6:24-8. (in Ukrainian).

Petrynych OA. Effect of pioglitazone on metabolic parameters in patients with hypertension combined with diabetes of the second type. Klinichna ta eksperymental'na patolohiia. 2010;9(4):74-8. (in Ukrainian).

Petrynych OA. The use of S-amlodipine and its combination with lisinopril in hypertensive patients: impact on hemodynamic and metabolic parameters. Aktual'ni problemy suchasnoi medytsyny. Visnyk Ukrains'koi medychnoi stomatolohichnoi akademii. 2010;10(3):219-4. (in Ukrainian).

Petrynych OA. Lipid peroxidation and antioxidant protection in hypertensive patients and in combination with diabetes mellitus type 2. Klinichna ta eksperymental'na patolohiia. 2009;VIII(3):74-8. (in Ukrainian).

Petrynych OA, Bilets'kyi SV. State of hemostasis and proteolysis in hypertensive patients and with concomitant diabetes mellitus type 2 diabetes: relationship with metabolic disorders. Halyts'kyi likars'kyi visnyk. 2009;16(4):66-9. (in Ukrainian).

Kovalenko VM. “ed.”. The health of the people of Ukraine due to illness circulatory system and possible ways of its improvement. Kyiv; 2004. 124 p. (in Ukrainian).

Chekman IS, Datsiuk NO. The role of lipid peroxidation in the pathogenesis of hypertension. Sertse i sudyny. 2008;4:110-5. (in Ukrainian).

Davy KP, Hall JE. Obesity and hypertension: two epidemics or one? Amer. J. Physiol. Regul. Integr. Comp. Physiol. 2004;286:R803-3.

Ding Y, Li YM, Zimmerman M. Role of CuZn superoxide dismutase on carotid body function in heart failure rabbits. Сardiovasc. Res. 2009;81:678-5.

Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia. 2003;46(12):1594-3.

Hotamisligil GS. Inflammatory pathways and insulin action. Int. J. Obes. Relat. Metab. Disord. 2003;27:S53-5.

Levy D, Garrison RJ, Savage DD. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New Engl. J. Med . 1990;322:1561-6.

##submission.downloads##

Опубліковано

2014-05-02

Номер

Розділ

СТОРІНКИ ІСТОРІЇ